HCPCS Level II drug code
J9299 — Injection, nivolumab, 1 mg
In short
J9299 is the HCPCS Level II code for injection, nivolumab, 1 mg. CMS assigns NDCs for Opdivo to it. One billing unit is 1 mg. The Medicare Part B payment limit is $34.191 per unit (October 1, 2026 through December 31, 2026).
Code
Med-Code curated- Descriptor
- Injection, nivolumab, 1 mg
- Code set
- HCPCS Level II, maintained by CMS
- Category
- Chemotherapy / Immunotherapy
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 1 mg. For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Drugs mapped to J9299
FDA-listed products billed under J9299
Finished products in the FDA NDC Directory whose brand or single active ingredient, and route, match this code’s entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Opdivonivolumab | Nivolumab 10 mg/mL | InjectionIntravenous | E.R. Squibb & Sons, L.L.C. | 0003-3772 |
| Opdivonivolumab | Nivolumab 10 mg/mL | InjectionIntravenous | E.R. Squibb & Sons, L.L.C. | 0003-3734 |
| Opdivonivolumab | Nivolumab 10 mg/mL | InjectionIntravenous | E.R. Squibb & Sons, L.L.C. | 0003-3774 |
| Opdivonivolumab | Nivolumab 10 mg/mL | InjectionIntravenous | E.R. Squibb & Sons, L.L.C. | 0003-3756 |
All NDCs for these drugs
NDCs billed under J9299
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 4 NDCs to J9299 for Opdivo. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Opdivo | 00003-3734-13 | E.R. Squibb & Sons, L.L.C. | 24 | 240 |
| Opdivo | 00003-3756-14 | E.R. Squibb & Sons, L.L.C. | 12 | 120 |
| Opdivo | 00003-3772-11 | E.R. Squibb & Sons, L.L.C. | 4 | 40 |
| Opdivo | 00003-3774-12 | E.R. Squibb & Sons, L.L.C. | 10 | 100 |
J9299: common questions
- Is J9299 a CPT code?
- No. J9299 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J9299?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 4 NDCs under J9299, for Opdivo. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J9299?
- $34.191 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J9299?
- One unit of J9299 is 1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg. J-code billing units.